Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Identification of virus-specific B-cell epitopes by convalescent plasma from COVID-19 patients

Molecular Immunology(2022)10.1016/j.molimm.2022.10.016Source: DataRank Database

Identification of virus-specific B-cell epitopes by convalescent plasma from COVID-19 patients is a research paper published in Molecular Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 0.48)OA: hybridTopics (48)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Juan Zhao ORCID,Madison Schank ORCID,Sushant Khanal ORCID,Xindi Dang,Dechao Cao ORCID

Live enrichment

PubMed:36379129 PMC:PMC9630139 OpenAlex:https://openalex.org/W4308488374

U.S. Department of Veterans Affairs

Grant: 1I01BX004281

U.S. Department of Veterans Affairs

Grant: 1I01BX002670

U.S. Department of Veterans Affairs

Grant: 5I01BX005428

U.S. Department of Veterans Affairs

Grant: 7\u201320-COVID-149

US Department of Defense

Grant: PR170067

National Institutes of Health

Grant: R21AI157909

National Institutes of Health

Grant: R15AG069544

BLRD VA

Grant: I01 BX004281

BLRD VA

Grant: I01 BX005428

BLRD VA

Grant: I01 BX002670

NIH HHS

Grant: S10 OD021572

National Institutes of Health

Grant: 1I01BX004281-01A1

Telomere loss and T cell aging in HBV vaccine response in HCV-infected individual

National Institutes of Health

Grant: 5I01BX002670-04

Premature T cell aging and vaccine failure in chronic viral infection

National Institutes of Health

Grant: 5R21AI157909-02

Dual specific gene editing drugs delivered by nanoparticles targeting HBV/HIV coinfection

National Institutes of Health

Grant: 3R15AG069544-01A1S1

Mitochondrial Dysfunction in Aging CD4 T cells in HIV-immune Non-responders.

National Institutes of Health

Grant: 1I01BX005428-01

COVID-19: Characterizing trained immune responses to COVID-19

FWCI

0.48

Citation Percentile

0.6%

Citation Trend

2024

2025

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.molimm.2022.10.016

publisherhttps://doi.org/10.1016/j.molimm.2022.10.016

publisherhttps://api.elsevier.com/content/article/PII:S0161589022004618?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0161589022004618?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36379129

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 Impact on Reproduction0301 basic medicine03 medical and health sciencesHumansCOVID-19SARS-CoV-2Epitopes, B-LymphocyteSpike Glycoprotein, CoronavirusLeukocytes, MononuclearAntibodies, ViralAntibodies, NeutralizingCOVID-19 Serotherapy

MeSH Terms

COVID-19SARS-CoV-2COVID-19 SerotherapyAntibodies, ViralHumansLeukocytes, MononuclearEpitopes, B-LymphocyteAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

Convalescent plasmaVirologyEpitopeCoronavirus disease 2019 (COVID-19)Identification (biology)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirusMedicineBiologyAntibodyImmunologyInternal medicineDiseaseB-cell EpitopesNeutralizing AntibodiesCovid-19Sars-cov-2Spike Glycoprotein, CoronavirusLeukocytes, MononuclearHumansEpitopes, B-LymphocyteAntibodies, ViralAntibodies, NeutralizingArticleCOVID-19 Serotherapy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being